tiprankstipranks
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
US Market

Sorrento Therapeutics (SRNE) Income Statement

Compare
5,267 Followers

Sorrento Therapeutics Income Statement

Last quarter (Q2 2023), Sorrento Therapeutics's total revenue was $15.03M, an increase of 31.10% from the same quarter last year. In Q2, Sorrento Therapeutics's net income was $-95.21M. See Sorrento Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 62.84M$ 52.90M$ 39.99M$ 31.43M$ 21.19M
Gross Profit
$ 29.39M$ 39.87M$ 30.05M$ 19.20M$ 11.12M
Operating Expenses
$ 533.70M$ 407.92M$ 231.57M$ 214.38M$ 140.60M
Depreciation and Amortization
$ 13.24M$ 16.32M$ 14.71M$ 15.04M$ 9.05M
EBITDA
$ -539.93M$ -435.99M$ -275.69M$ -308.39M$ -147.10M
Operating Income
$ -504.31M$ -368.05M$ -201.53M$ -195.18M$ -129.48M
Other Income/Expenses
$ -57.43M$ -94.48M$ -66.06M$ -100.18M$ -63.36M
Pretax Income
$ -561.75M$ -462.53M$ -310.58M$ -359.58M$ -213.78M
Net Income
$ -572.84M$ -429.01M$ -308.57M$ -359.10M$ -203.54M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.37$ -1.46$ -1.34$ -2.56$ -1.92
Diluted EPS
$ -1.37$ -1.46$ -1.34$ -2.56$ -1.92
Weighted Average Shares Outstanding
419.31M 294.77M 229.82M 140.51M 106.15M
Weighted Average Shares Outstanding (Diluted)
419.31M 294.77M 229.82M 140.51M 106.15M
Currency in USD

Sorrento Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis